GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...

Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.

Auricular acupressure in patients with functional dyspepsia and insomnia led to improved sleep and was well-tolerated, with benefits lasting beyond the treatment duration.

There’s been a seismic shift in men’s locker rooms. The familiar musk of sweat has been replaced by eucalyptus and juniper.

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

January 8, 2026 - By Amy Anderson - Adults aged 65 and older's desire to lose weight is frequently centered around improving functional ability and health outcomes, which may differ from those of ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.

GSK announced in January that its novel chronic hepatitis B (CHB) successfully met primary goals in two pivotal phase 3 ...

The minimalist beauty brand founded by Hailey Bieber is launching in Australia and New Zealand via an exclusive retail ...

For decades, treating major depression has involved a frustrating cycle of trial and error, with patients cycling through ...